PLC GLAXOSMITHKLINE Insider Trading $THRX Innoviva, Inc.
Get free email notifications about insider trading for PLC GLAXOSMITHKLINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PLC GLAXOSMITHKLINE. PLC GLAXOSMITHKLINE is 10% Owner in QUEST DIAGNOSTICS INC ($DGX) and Director in QUEST DIAGNOSTICS INC ($DGX) and 10% Owner in EPIX Pharmaceuticals, Inc. ($EPIX) and 10% Owner in MAXYGEN INC ($MAXY) and 10% Owner in Innoviva, Inc. ($THRX) and in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and 10% Owner in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and in Liquidia Technologies Inc ($LQDA) and 10% Owner in Redpoint Bio CORP ($RPBC) and in NUPATHE INC. ($PATH) and 10% Owner in Anacor Pharmaceuticals, Inc. ($ANAC) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and in Principia Biopharma Inc. ($PRNB) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in Progyny, Inc. ($PGNY) and 10% Owner in Theravance Biopharma, Inc. ($TBPH) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Fulcrum Therapeutics, Inc. ($FULC) and 10% Owner in CRISPR Therapeutics AG ($CRSP) and 10% Owner in Spero Therapeutics, Inc. ($SPRO) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC) and Director in BICYCLE THERAPEUTICS plc ($BCYC) and Director in Nkarta, Inc. ($NKTX) and Director in Pandion Therapeutics, Inc. ($PAND).
PLC GLAXOSMITHKLINE in Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PLC GLAXOSMITHKLINE: 10% Owner
Holdings: 32,005,260 shares
Latest Transaction: Aug 07 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PLC GLAXOSMITHKLINE in Innoviva, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, ANAC, AGTC, BCYC, CCXI, CRSP, EPIX, FULC, GNCA, HTGM, THRX, LIQDA, MAXY, NKTX, PATH, PAND, PRNB, PGNY, DGX, RPBC, SPRO, TBPH, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 07 2015 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 3,485,840.00 | 245,828 | 856,917,331,181 | 32,005,260 | 31.8 M to 32 M (+0.77 %) |
| May 11 2015 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 1,369,260.00 | 85,579 | 117,180,243,856 | 31,759,432 | 31.7 M to 31.8 M (+0.27 %) |
| Mar 02 2015 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 1,673,690.00 | 92,674 | 155,107,773,185 | 31,673,853 | 31.6 M to 31.7 M (+0.29 %) |
| Aug 11 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 3,912,270.00 | 172,651 | 675,457,614,371 | 30,748,723 | 30.6 M to 30.7 M (+0.56 %) |
| May 13 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 8,544,840.00 | 317,770 | 2,715,292,313,281 | 30,576,072 | 30.3 M to 30.6 M (+1.05 %) |
| Feb 13 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 12,850,700.00 | 342,229 | 4,397,881,850,960 | 30,258,302 | 29.9 M to 30.3 M (+1.14 %) |
| Oct 29 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 4,913,610.00 | 130,473 | 641,093,852,434 | 29,916,073 | 29.8 M to 29.9 M (+0.44 %) |
| Aug 01 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 100,000,000.00 | 3,064,407 | 306,440,699,999,690 | 29,785,600 | 26.7 M to 29.8 M (+11.47 %) |
| Apr 30 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 6,699,220.00 | 193,563 | 1,296,720,236,277 | 26,721,193 | 26.5 M to 26.7 M (+0.73 %) |
| Feb 20 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 2,567,090.00 | 116,527 | 299,135,274,290 | 26,527,630 | 26.4 M to 26.5 M (+0.44 %) |
| Nov 05 2012 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 6,265,780.00 | 280,348 | 1,756,598,274,674 | 26,411,103 | 26.1 M to 26.4 M (+1.07 %) |
| May 16 2012 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 21.29 | 10,000,000 | 212,887,000 | 25,814,421 | 15.8 M to 25.8 M (+63.23 %) |
| Feb 14 2012 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 18.12 | 88,468 | 1,603,040 | 15,814,421 | 15.7 M to 15.8 M (+0.56 %) |
| Nov 03 2011 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 22.23 | 58,411 | 1,298,477 | 15,725,953 | 15.7 M to 15.7 M (+0.37 %) |
| Aug 03 2011 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 19.71 | 102,466 | 2,019,605 | 15,667,542 | 15.6 M to 15.7 M (+0.66 %) |
| Jul 25 2011 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 9,401,499 | 0 | 0 | |
| Jul 25 2011 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 9,401,499 | 0 | 15,565,076 | 6.2 M to 15.6 M (+152.53 %) |
| May 04 2011 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 25.60 | 261,299 | 6,689,254 | 6,163,577 | 5.9 M to 6.2 M (+4.43 %) |
| Feb 22 2011 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 23.70 | 152,278 | 3,608,989 | 5,902,278 | 5.8 M to 5.9 M (+2.65 %) |
| Nov 30 2010 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 22.50 | 5,750,000 | 129,375,000 | 5,750,000 | 0 to 5.8 M |
| Oct 12 2004 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | P | 0.00 | 433,757 | 0 | 9,401,498 |
Page: 1